Atreca Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11203
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atreca Inc (Atreca) is a biotechnology company that develops and develops novel therapies based on the human immune response. The company develops proprietary immune repertoire capture technology that act as an engine for the discovery and development of antibody based therapeutics, diagnostics, vaccines and research reagents. Its technology has partnerships with pharmaceutical companies, academic institutions, non-profit foundations and governmental entities. Its pipeline products are intended for the treatment of breast tumor, lung tumor, colon tumor and other solid tumors. Atreca is headquartered in Redwood City, California, the US.

Atreca Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9
Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Atreca Raises USD125 Million in Series C Venture Financing 12
Atreca Raises USD35 Million in Series B Financing 14
Atreca Raises USD56 Million in Series A Financing 15
Atreca Raises USD57.26 Million in Venture Financing 16
Atreca Raises USD0.7 Million in Venture Financing 17
Atreca Raises USD0.05 Million in Venture Financing 18
Atreca Raises USD3 Million in Venture Financing 19
Atreca Raises Funds through Venture Financing 20
Atreca Raises USD0.4 Million in Venture Financing 21
Partnerships 22
Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22
Atreca Enters into Agreement with Genome Institute of Singapore 23
Atreca Enters into Research Agreement with Janssen Biotech 24
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25
Licensing Agreements 26
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26
Atreca Inc – Key Competitors 27
Atreca Inc – Key Employees 28
Atreca Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Corporate Communications 30
Apr 19, 2018: Atreca Names John A. Orwin As President and CEO 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9
Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atreca Raises USD125 Million in Series C Venture Financing 12
Atreca Raises USD35 Million in Series B Financing 14
Atreca Raises USD56 Million in Series A Financing 15
Atreca Raises USD57.26 Million in Venture Financing 16
Atreca Raises USD0.7 Million in Venture Financing 17
Atreca Raises USD0.05 Million in Venture Financing 18
Atreca Raises USD3 Million in Venture Financing 19
Atreca Raises Funds through Venture Financing 20
Atreca Raises USD0.4 Million in Venture Financing 21
Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22
Atreca Enters into Agreement with Genome Institute of Singapore 23
Atreca Enters into Research Agreement with Janssen Biotech 24
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26
Atreca Inc, Key Competitors 27
Atreca Inc, Key Employees 28

List of Figures
Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Atreca Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WPX Energy Inc (WPX):企業の財務・戦略的SWOT分析
    WPX Energy Inc (WPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mirach Energy Ltd (AWO):石油・ガス:M&Aディール及び事業提携情報
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …
  • IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • Power Machines:企業の戦略的SWOT分析
    Power Machines - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EMIS Group plc (EMIS):企業の財務・戦略的SWOT分析
    Summary EMIS Group Plc (EMIS), formerly Egton Medical Information Systems Ltd, is a provider of information technology and related services. The company provides electronic patient record systems and software solutions such as EMIS web, used for clinical services; EMIS IQ for data extraction; and sy …
  • Sirtex Medical Ltd (SRX):企業の財務・戦略的SWOT分析
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Athena Investments AS (ATHENA):企業の財務・戦略的SWOT分析
    Athena Investments AS (ATHENA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Chr. Hansen Holding AS (CHR):製薬・医療:M&Aディール及び事業提携情報
    Summary Chr. Hansen Holding A/S (Chr. Hansen) is a bioscience company that focuses on the development of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. It …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Waters Corp (WAT):企業の財務・戦略的SWOT分析
    Waters Corp (WAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UltraTech Cement Ltd:戦略・SWOT・企業財務分析
    UltraTech Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary UltraTech Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Olin Corporation:企業の戦略・SWOT・財務情報
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Adgero Biopharmaceuticals Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Adgero Biopharmaceuticals Holdings Inc (Adgero) is a biopharmaceutical company which advances its proprietary late stage photodynamic therapy (PDT) for the treatment of unmet clinical needs of patients with cutaneous metastatic breast cancer (CMBC) and bile duct cancer. Its PDT is a treatmen …
  • BioFire Diagnostics LLC:企業の製品パイプライン分析2018
    Summary BioFire Diagnostics LLC (BioFire Diagnostics), formerly Idaho Technology Inc, a subsidiary of bioMerieux SA, is a molecular diagnostics company that offers molecular biology products. The company offers solutions for healthcare providers, labs and customers. It provides respiratory, meningit …
  • Steel Excel Inc (SXCL):企業の財務・戦略的SWOT分析
    Summary Steel Excel Inc (Steel Excel) is a provider of technology consulting and business development solutions. The company’s services comprise rogue pressure services, sun well services, black hawk energy services, functional fitness facilities, sports training, strength and conditioning gym facil …
  • SJVN Ltd (SJVN):企業の財務・戦略的SWOT分析
    SJVN Ltd (SJVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cardinal Health, Inc.:企業の戦略・SWOT・財務情報
    Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆